MedTrace Logo

Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage

NCT01108523 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2013-12-06

Study results available
· View outcomes & findings →

Summary

This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.

Conditions

  • Skin Abnormalities

Interventions

DEVICE

HP828-101

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint

  • Neeta Nayak, MD · Golden Acres

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-07-31
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108523 on ClinicalTrials.gov